New hope for hepatitis b: experimental drug combo shows promise
NCT ID NCT05612581
First seen Dec 17, 2025 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This study tested new drug combinations in 33 adults with chronic hepatitis B, a long-term liver infection. The goal was to see if the treatments could lower the virus to undetectable levels and reduce a key marker of infection (HBsAg). The trial is part of a larger effort to find better ways to control the disease, though it is not expected to be a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigative Site
Clichy, 92110, France
-
Investigative Site
Nice, 06200, France
-
Investigative Site
Rennes, 35000, France
-
Investigative Site
Toulouse, 31000, France
-
Investigative Site
Hong Kong, Sha Tin, Hong Kong
-
Investigative Site
Hong Kong, Hong Kong
-
Investigative Site
Chisinau, MD 2025, Moldova
-
Investigative Site
Bucharest, 021105, Romania
-
Investigative Site
Busan, 49241, South Korea
-
Investigative Site
Seoul, 5505, South Korea
-
Investigative Site
Yangsan, 50612, South Korea
-
Investigative Site
Glasgow, G4 0SF, United Kingdom
-
Investigative Site
London, EC1A 7BE, United Kingdom
-
Investigative Site
London, SE5 9RS, United Kingdom
-
Investigative Site
Manchester, M8 5RB, United Kingdom
Conditions
Explore the condition pages connected to this study.